MSP1830 Citations (3)

Originally described in: Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition.
Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK Nat Biotechnol. 2015 Nov 2. doi: 10.1038/nbt.3404. PubMed Journal

---

Articles Citing MSP1830

Articles
Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA. Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15. PubMed
Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis. Shi Z, Jiang H, Liu G, Shi S, Zhang X, Chen Y. Cell Biosci. 2022 Jul 8;12(1):104. doi: 10.1186/s13578-022-00841-3. PubMed
Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease. Tan K, Siller DDB, Xiong AY, Wang AXA, McCallister TX, Mummadi S, St John LA, Lee TK, Carrillo A, Renshaw DG, Zhou RH, Lim CKW, He J, Fields CJ, Hayden MR, Gaj T. bioRxiv [Preprint]. 2025 Dec 22:2025.12.20.695720. doi: 10.64898/2025.12.20.695720. PubMed

If you have published an article using this material, please email us at to have your article added to this page.